Reliability of antimalarial sensitivity tests depends on drug mechanisms of action

Journal of Clinical Microbiology

Volumn 48, Issue 5, 2010, Pages 1651-1660

  Wein, Sharon ^a   Maynadier, Marjorie ^a   Van Ba, Christophe Tran ^a   Cerdan, Rachel ^a   Peyrottes, Suzanne ^b   Fraisse, Laurent ^c   Vial, Henri ^a  

^a UNIVERSITÉ DE MONTPELLIER   (France)

^b UNIVERSITÉ DE MONTPELLIER   (France)

^c SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; ATOVAQUONE; CHOLINE DERIVATIVE; DOXYCYCLINE; ETHANOLAMINE; HYPOXANTHINE; PYRIMETHAMINE;

ARTICLE; DNA CONTENT; ENZYME LINKED IMMUNOSORBENT ASSAY; IN VITRO STUDY; INCUBATION TIME; MEDICAL INFORMATION; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

ANTIMALARIALS; HUMANS; INHIBITORY CONCENTRATION 50; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; TIME FACTORS;

ARTESUNATE;

EID: 77951845456     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02250-09     Document Type: Article

References (47)

1. Ancelin, M. L., M. Calas, J. Bompart, G. Cordina, D. Martin, M. Ben Bari, T. Jei, P. Druilhe, and H. J. Vial. 1998. Antimalarial activity of 77 phospholipid polar head analogs: close correlation between inhibition of phospholipid metabolism and in vitro Plasmodium falciparum growth. Blood 91:1426-1437.
2. Ancelin, M. L., M. Calas, A. Bonhoure, S. Herbute, and H. J. Vial. 2003. In vivo antimalarial activities of mono- and bis-quaternary ammonium salts interfering with Plasmodium phospholipid metabolism. Antimicrob. Agents Chemother. 47:2598-2605.
3. Ancelin, M. L., M. Calas, V. Vidal-Sailhan, S. Herbute, P. Ringwald, and H. J. Vial. 2003. Potent inhibitors of Plasmodium phospholipid metabolism with a broad spectrum of in vitro antimalarial activities. Antimicrob. Agents Chemother. 47:2590-2597.
4. Bacon, D. J., C. Latour, C. Lucas, O. Colina, P. Ringwald, and S. Picot. 2007. Comparison of a SYBR green I-based assay with a histidine-rich protein II enzyme-linked immunosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates. Antimicrob. Agents Chemother. 51:1172-1178.
5. Barends, M., A. Jaidee, N. Khaohirun, P. Singhasivanon, and F. Nosten. 2007. In vitro activity of ferroquine (SSR 97193) against Plasmodium falciparum isolates from the Thai-Burmese border. Malaria J. 6:81.
6. Biagini, G. A., E. M. Pasini, R. Hughes, H. P. De Koning, H. J. Vial, P. M. O'Neill, S. A. Ward, and P. G. Bray. 2004. Characterization of the choline carrier of Plasmodium falciparum: a route for the selective delivery of novel antimalarial drugs. Blood 104:3372-3377.
7. Biagini, G. A., E. Richier, P. G. Bray, M. Calas, H. Vial, and S. A. Ward. 2003. Heme binding contributes to antimalarial activity of bis-quaternary ammoniums. Antimicrob. Agents Chemother. 47:2584-2589.
8. Briolant, S., M. Baragatti, P. Parola, F. Simon, A. Tall, C. Sokhna, P. Hovette, M. M. Mamfoumbi, J. L. Koeck, J. Delmont, A. Spiegel, J. Castello, J. P. Gardair, J. F. Trape, M. Kombila, P. Minodier, T. Fusai, C. Rogier, and B. Pradines. 2009. Multinormal in vitro distribution model suitable for the distribution of Plasmodium falciparum chemosusceptibility to doxycycline. Antimicrob. Agents Chemother. 53:688-695.
9. Burkhardt, D., J. Wiesner, N. Stoesser, M. Ramharter, A. C. Uhlemann, S. Issifou, H. Jomaa, S. Krishna, P. G. Kremsner, and S. Borrmann. 2007. Delayed parasite elimination in human infections treated with clindamycin parallels "delayed death" of Plasmodium falciparum in vitro. Int. J. Parasitol. 37:777-785.
10. Carlson, J., H. Helmby, A. V. Hill, D. Brewster, B. M. Greenwood, and M. Wahlgren. 1990. Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies. Lancet 336:1457-1460.
11. Dahl, E. L., and P. J. Rosenthal. 2007. Multiple antibiotics exert delayed effects against the Plasmodium falciparum apicoplast. Antimicrob. Agents Chemother. 51:3485-3490.
12. Desjardins, R. E., C. J. Canfield, J. D. Haynes, and J. D. Chulay. 1979. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob. Agents Chemother. 16:710-718.
13. Divo, A. A., T. G. Geary, and J. B. Jensen. 1985. Oxygen- and time-dependent effects of antibiotics and selected mitochondrial inhibitors on Plasmodium falciparum in culture. Antimicrob. Agents Chemother. 27:21-27.
14. Dondorp, A. M., F. Nosten, P. Yi, D. Das, A. P. Phyo, J. Tarning, K. M. Lwin, F. Ariey, W. Hanpithakpong, S. J. Lee, P. Ringwald, K. Silamut, M. Imwong, K. Chotivanich, P. Lim, T. Herdman, S. S. An, S. Yeung, P. Singhasivanon, N. P. Day, N. Lindegardh, D. Socheat, and N. J. White. 2009. Artemisinin resistance in Plasmodium falciparum malaria. N. Engl. J. Med. 361:455-467.
15. Druilhe, P., A. Moreno, C. Blanc, P. H. Brasseur, and P. Jacquier. 2001. A colorimetric in vitro drug sensitivity assay for Plasmodium falciparum based on a highly sensitive double-site lactate dehydrogenase antigen-capture enzyme-linked immunosorbent assay. Am. J. Trop. Med. Hyg. 64:233-241.
16. Elabbadi, N., M. L. Ancelin, and H. J. Vial. 1992. Use of radioactive ethanolamine incorporation into phospholipids to assess in vitro antimalarial activity by the semiautomated microdilution technique. Antimicrob. Agents Chemother. 36:50-55.
17. Goodman, C. D., V. Su, and G. I. McFadden. 2007. The effects of antibacterials on the malaria parasite Plasmodium falciparum. Mol. Biochem. Parasitol. 152:181-191.
18. Greenwood, B. M., D. A. Fidock, D. E. Kyle, S. H. Kappe, P. L. Alonso, F. H. Collins, and P. E. Duffy. 2008. Malaria: progress, perils, and prospects for eradication. J. Clin. Invest. 118:1266-1276.
19. Iqbal, J., A. Siddique, M. Jameel, and P. R. Hira. 2004. Persistent histidine-rich protein 2, parasite lactate dehydrogenase, and panmalarial antigen reactivity after clearance of Plasmodium falciparum monoinfection. J. Clin. Microbiol. 42:4237-4241.
20. Johnson, J. D., R. A. Dennull, L. Gerena, M. Lopez-Sanchez, N. E. Roncal, and N. C. Waters. 2007. Assessment and continued validation of the malaria SYBR green I-based fluorescence assay for use in malaria drug screening. Antimicrob. Agents Chemother. 51:1926-1933.
21. Kaddouri, H., A. Djimde, S. Dama, A. Kodio, M. Tekete, V. Hubert, A. Kone, H. Maiga, O. Yattara, B. Fofana, B. Sidibe, C. P. Sangare, O. Doumbo, and J. Le Bras. 2008. Baseline in vitro efficacy of ACT component drugs on Plasmodium falciparum clinical isolates from Mali. Int. J. Parasitol. 38:791-798.
22. Lambros, C., and J. P. Vanderberg. 1979. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J. Parasitol. 65:418-420.
23. Lang-Unnasch, N., and A. D. Murphy. 1998. Metabolic changes of the malaria parasite during the transition from the human to the mosquito host. Annu. Rev. Microbiol. 52:561-590.
24. Le Roch, K. G., J. R. Johnson, H. Ahiboh, D. W. Chung, J. Prudhomme, D. Plouffe, K. Henson, Y. Zhou, W. Witola, J. R. Yates, C. B. Mamoun, E. A. Winzeler, and H. Vial. 2008. A systematic approach to understand the mechanism of action of the bisthiazolium compound T4 on the human malaria parasite, Plasmodium falciparum. BMC Genomics 9:513.
25. Makler, M. T., J. M. Ries, J. A. Williams, J. E. Bancroft, R. C. Piper, B. L. Gibbins, and D. J. Hinrichs. 1993. Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity. Am. J. Trop. Med. Hyg. 48:739-741.
26. Noedl, H., J. Bronnert, K. Yingyuen, B. Attlmayr, H. Kollaritsch, and M. Fukuda. 2005. Simple histidine-rich protein 2 double-site sandwich enzyme-linked immunosorbent assay for use in malaria drug sensitivity testing. Antimicrob. Agents Chemother. 49:3575-3577.
27. Noedl, H., S. Krudsood, W. Leowattana, N. Tangpukdee, W. Thanachartwet, S. Looareesuwan, R. S. Miller, M. Fukuda, K. Jongsakul, K. Yingyuen, S. Sriwichai, C. Ohrt, and C. Knirsch. 2007. In vitro antimalarial activity of azithromycin, artesunate, and quinine in combination and correlation with clinical outcome. Antimicrob. Agents Chemother. 51:651-656.
28. Noedl, H., D. Socheat, and W. Satimai. 2009. Artemisinin-resistant malaria in Asia. N. Engl. J. Med. 361:540-541.
29. Noedl, H., C. Wongsrichanalai, R. S. Miller, K. S. Myint, S. Looareesuwan, Y. Sukthana, V. Wongchotigul, H. Kollaritsch, G. Wiedermann, and W. H. Wernsdorfer. 2002. Plasmodium falciparum: effect of anti-malarial drugs on the production and secretion characteristics of histidine-rich protein II. Exp. Parasitol. 102:157-163.
30. Noedl, H., C. Wongsrichanalai, and W. H. Wernsdorfer. 2003. Malaria drug-sensitivity testing: new assays, new perspectives. Trends Parasitol. 19:175-181. (Pubitemid 36411974)
31. Olliaro, P. L., R. K. Haynes, B. Meunier, and Y. Yuthavong. 2001. Possible modes of action of the artemisinin-type compounds. Trends Parasitol. 17: 122-126.
32. Plouffe, D., A. Brinker, C. McNamara, K. Henson, N. Kato, K. Kuhen, A. Nagle, F. Adrian, J. T. Matzen, P. Anderson, T. G. Nam, N. S. Gray, A. Chatterjee, J. Janes, S. F. Yan, R. Trager, J. S. Caldwell, P. G. Schultz, Y. Zhou, and E. A. Winzeler. 2008. In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen. Proc. Natl. Acad. Sci. U. S. A. 105:9059-9064.
33. Pradines, B., A. Spiegel, C. Rogier, A. Tall, J. Mosnier, T. Fusai, J. F. Trape, and D. Parzy. 2000. Antibiotics for prophylaxis of Plasmodium falciparum infections: in vitro activity of doxycycline against Senegalese isolates. Am. J. Trop. Med. Hyg. 62:82-85.
34. Rason, M. A., T. Randriantsoa, H. Andrianantenaina, A. Ratsimbasoa, and D. Menard. 2008. Performance and reliability of the SYBR green I-based assay for the routine monitoring of susceptibility of Plasmodium falciparum clinical isolates. Trans. R. Soc. Trop. Med. Hyg. 102:346-351.
35. Sidhu, A. B., Q. Sun, L. J. Nkrumah, M. W. Dunne, J. C. Sacchettini, and D. A. Fidock. 2007. In vitro efficacy, resistance selection, and structural modeling studies implicate the malarial parasite apicoplast as the target of azithromycin. J. Biol. Chem. 282:2494-2504.
36. Skinner, T. S., L. S. Manning, W. A. Johnston, and T. M. Davis. 1996. In vitro stage-specific sensitivity of Plasmodium falciparum to quinine and artemisinin drugs. Int. J. Parasitol. 26:519-525.
37. Smilkstein, M., N. Sriwilaijaroen, J. X. Kelly, P. Wilairat, and M. Riscoe. 2004. Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening. Antimicrob. Agents Chemother. 48:1803-1806.
38. Terkuile, F., N. J. White, P. Holloway, G. Pasvol, and S. Krishna. 1993. Plasmodium falciparum: in vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria. experimental parasitology 76:85-95.
39. Trager, W., and J. B. Jensen. 1976. Human malaria parasites in continuous culture. Science 193:673-675.
40. Vial, H. J., and M. L. Ancelin. 1992. Malarial lipids: an overview. Subcell. Biochem. 18:259-306.
41. Vial, H. J., and C. Ben Mamoun. 2005. Plasmodium lipids: metabolism and function, p. 327-352. In I. W. Sherman (ed.), Molecular approaches to malaria. ASM Press, Washington, DC.
42. Vial, H. J., P. Eldin, A. G. Tielens, and J. J. van Hellemond. 2003. Phospholipids in parasitic protozoa. Mol. Biochem. Parasitol. 126:143-154.
43. Vial, H. J., S. Wein, C. Farenc, C. Kocken, O. Nicolas, M. L. Ancelin, F. Bressolle, A. Thomas, and M. Calas. 2004. Prodrugs of bisthiazolium salts are orally potent antimalarials. Proc. Natl. Acad. Sci. U. S. A. 101:15458-15463.
44. Wellems, T. E., and R. J. Howard. 1986. Homologous genes encode two distinct histidine-rich proteins in a cloned isolate of Plasmodium falciparum. Proc. Natl. Acad. Sci. U. S. A. 83:6065-6069.
45. Wengelnik, K., V. Vidal, M. L. Ancelin, A. M. Cathiard, J. L. Morgat, C. H. Kocken, M. Calas, S. Herrera, A. W. Thomas, and H. J. Vial. 2002. A class of potent antimalarials and their specific accumulation in infected erythrocytes. Science 295:1311-1314. (Pubitemid 34157625)
46. World Health Organization. 2008. Roll Back Malaria: the global malaria action plan for a malaria-free world. World Health Organization, Geneva, Switzerland. http://www.rollbackmalaria.org/gmap/index.html.
47. World Health Organization. 2008. World malaria report 2008. World Health Organization, Geneva, Switzerland. http://www.who.int/malaria/wmr2008/.